Clinical trial
Treatment of Patients With COVID-19 With Convalescent Plasma Transfusion: a Multicenter, Open-labeled, Randomized and Controlled Study
NCT04415086 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Patients With COVID-19 With Convalescent Plasma Transfusion: a Multicenter, Open-labeled, Randomized and Controlled Study
- Lead sponsor
- University of Sao Paulo General Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 1, 2020
- Completion date
- February 15, 2022
- Enrollment
- 129 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.